Neovasc Announces Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer for Treatment of Refractory Angina mydrg.de

scatter_plot

Neovasc Announces Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer for Treatment of Refractory Angina

• B.S.
• Freitag, 31.01.2020

Neovasc Announces Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer for Treatment of Refractory Angina (GlobeNewswire).

InEK - Innovationen - Krankenhausabrechnung - Leitlinien - Medizinprodukte - Mitralklappen Clip-Rekonstruktion - NUB 2020 - Reducer - refraktäre Angina pectoris - Reimbursement - Sinus coronarius Koronarvenensinus - Therapie - URL

« Qualitätsbeurteilungs-Richtlinie Kernspintomographie | Neovasc Announces Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer for Treatment of Refractory Angina | Verordnungshäufigkeit von Biosmilars der TNF alpha Inhibitoren »